Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

  1. Home
  2. Plasma Sqstm1/p62 Act As A Biomarker For Steroid-induced Osteonecrosis Of The Femoral Head.
  1. Home
  2. Plasma Sqstm1/p62 Act As A Biomarker For Steroid-induced Osteonecrosis Of The Femoral Head.

Related Experiment Video

Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
05:55

Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head

Published on: September 27, 2024

475

Plasma SQSTM1/p62 act as a biomarker for steroid-induced osteonecrosis of the femoral head.

Wenyuan Hou1, Peng Peng1, Fangjun Xiao1

  • 1Guangzhou University of Chinese Medicine, Guangzhou, China.

Scientific Reports
|October 22, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

Plasma SQSTM1/p62 levels may help diagnose steroid-induced osteonecrosis of the femoral head (SIONFH). Lower levels indicate advanced SIONFH, offering potential for early detection.

Keywords:
AutophagyCollapseSQSTM1/p62Steroid-induced necrosis of the femoral head

More Related Videos

Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

6.5K
Production and Administration of Therapeutic Mesenchymal Stem/Stromal Cell MSC Spheroids Primed in 3-D Cultures Under Xeno-free Conditions
11:05

Production and Administration of Therapeutic Mesenchymal Stem/Stromal Cell MSC Spheroids Primed in 3-D Cultures Under Xeno-free Conditions

Published on: March 18, 2017

11.8K

Related Experiment Videos

Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
05:55

Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head

Published on: September 27, 2024

475
Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

6.5K
Production and Administration of Therapeutic Mesenchymal Stem/Stromal Cell MSC Spheroids Primed in 3-D Cultures Under Xeno-free Conditions
11:05

Production and Administration of Therapeutic Mesenchymal Stem/Stromal Cell MSC Spheroids Primed in 3-D Cultures Under Xeno-free Conditions

Published on: March 18, 2017

11.8K

Area of Science:

  • Biochemistry
  • Orthopedics
  • Cell Biology

Background:

  • Autophagy plays a key role in steroid-induced osteonecrosis of the femoral head (SIONFH) development and progression.
  • SQSTM1/p62 is a crucial indicator of cellular autophagic activity.

Purpose of the Study:

  • To investigate the role of SQSTM1/p62 in the pathogenesis of SIONFH.
  • To evaluate plasma SQSTM1/p62 as a potential biomarker for SIONFH staging.

Main Methods:

  • Recruited 36 SIONFH patients and 36 healthy controls.
  • Assessed SQSTM1/p62 expression in bone tissue and plasma.
  • Utilized imaging, pathologic assessment, and receiver operating characteristic (ROC) curves.

Main Results:

  • SQSTM1/p62 expression in bone decreased with increasing Association Research Circulation Osseous (ARCO) stage.
  • Plasma SQSTM1/p62 levels were significantly higher in SIONFH patients than controls.
  • Lower plasma SQSTM1/p62 levels correlated with advanced ARCO stages.
  • Conclusions:

    • Plasma SQSTM1/p62 may serve as a biomarker for SIONFH progression.
    • Decreased plasma SQSTM1/p62 levels are associated with advanced SIONFH stages.
    • This finding offers potential for the early diagnosis of SIONFH.